MedTrace Logo

Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment

NCT01596530 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2012-12-17

No results posted yet for this study

Summary

To compare the activity of AZD8931 against placebo on the cell markers in cancer tumours

Conditions

  • Breast Neoplasm

Interventions

DRUG

Drug-AZD8931

Active drug for biological activity

DRUG

Drug-Placebo

Placebo comparator for biological activity comparison

Sponsors & Collaborators

Principal Investigators

  • Serban Ghiorghiu, M.D. · Internal

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-03-31
Completion
2013-05-31

Countries

  • Germany
  • South Korea
  • Taiwan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01596530 on ClinicalTrials.gov